These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 31927332)

  • 61. A CD74-dependent MHC class I endolysosomal cross-presentation pathway.
    Basha G; Omilusik K; Chavez-Steenbock A; Reinicke AT; Lack N; Choi KB; Jefferies WA
    Nat Immunol; 2012 Feb; 13(3):237-45. PubMed ID: 22306692
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antigen bias in T cell cross-priming.
    Wolkers MC; Brouwenstijn N; Bakker AH; Toebes M; Schumacher TN
    Science; 2004 May; 304(5675):1314-7. PubMed ID: 15166378
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.
    den Haan JM; Lehar SM; Bevan MJ
    J Exp Med; 2000 Dec; 192(12):1685-96. PubMed ID: 11120766
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficient cross-presentation of soluble exogenous antigens introduced into dendritic cells using a weak-based amphiphilic peptide.
    Ikeuchi N; Futami J; Hosoi A; Noji S; Kurachi M; Ueha S; Fujii S; Yamada H; Matsushima K; Moriyasu F; Kakimi K
    Biochem Biophys Res Commun; 2010 Feb; 392(2):217-22. PubMed ID: 20067764
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cross-presentation: dendritic cells and macrophages bite off more than they can chew!
    Brode S; Macary PA
    Immunology; 2004 Jul; 112(3):345-51. PubMed ID: 15196201
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of mRNA translation in direct MHC class I antigen presentation.
    Apcher S; Manoury B; Fåhraeus R
    Curr Opin Immunol; 2012 Feb; 24(1):71-6. PubMed ID: 22341517
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.
    Di Pucchio T; Chatterjee B; Smed-Sörensen A; Clayton S; Palazzo A; Montes M; Xue Y; Mellman I; Banchereau J; Connolly JE
    Nat Immunol; 2008 May; 9(5):551-7. PubMed ID: 18376401
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination.
    Li L; Kim S; Herndon JM; Goedegebuure P; Belt BA; Satpathy AT; Fleming TP; Hansen TH; Murphy KM; Gillanders WE
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12716-21. PubMed ID: 22802630
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-lasting cross-presentation of tumor antigen in human DC.
    Faure F; Mantegazza A; Sadaka C; Sedlik C; Jotereau F; Amigorena S
    Eur J Immunol; 2009 Feb; 39(2):380-90. PubMed ID: 19130478
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses.
    Zhang QJ; Li XL; Wang D; Huang XC; Mathis JM; Duan WM; Knight D; Shi R; Glass J; Zhang DQ; Eisenbach L; Jefferies WA
    PLoS One; 2008 Aug; 3(8):e3097. PubMed ID: 18769733
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation.
    Imai J; Otani M; Sakai T; Hatta S
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28872140
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity.
    Blander JM
    Semin Immunol; 2023 Mar; 66():101713. PubMed ID: 36706521
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation.
    Martín-Orozco N; Isibasi A; Ortiz-Navarrete V
    Immunology; 2001 May; 103(1):41-8. PubMed ID: 11380691
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Class I MHC presentation of exogenous antigens.
    Harding CV
    J Clin Immunol; 1996 Mar; 16(2):90-6. PubMed ID: 8690777
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.
    François M; Romieu-Mourez R; Stock-Martineau S; Boivin MN; Bramson JL; Galipeau J
    Blood; 2009 Sep; 114(13):2632-8. PubMed ID: 19654411
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Peptide Channeling: The Key to MHC Class I Immunosurveillance?
    Yewdell JW; Dersh D; Fåhraeus R
    Trends Cell Biol; 2019 Dec; 29(12):929-939. PubMed ID: 31662235
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Redundancy renders the glycoprotein 96 receptor scavenger receptor A dispensable for cross priming in vivo.
    Tewalt EF; Maynard JC; Walters JJ; Schell AM; Berwin BL; Nicchitta CV; Norbury CC
    Immunology; 2008 Dec; 125(4):480-91. PubMed ID: 18489571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.